News in brief: Tilray launches pastilles; InhaleRx progresses panic disorder trial; NSW calls for hemp plan feedback; BS3 makes key hire by Steve Jones and Martin Lane April 23, 2025April 23, 2025 Tilray Medical has launched pastilles into the Australian market for the first time. Three medicines, each […]
InhaleRx prepares for pivotal trial in quest to provide relief from breakthrough cancer pain by cannabiz team January 29, 2025January 31, 2025
Five reasons why Australia is leading the way in cannabinoid research by Dr Sud Agarwal May 6, 2024May 6, 2024
Company news: Delta 9 Cannabis; Little Green Pharma; Zelira Therapeutics; Emyria by Martin Lane and Steve Jones February 16, 2023April 30, 2024
